Vitiligo develops when your immune system mistakenly attacks and destroys the cells that produce skin pigment. It is not contagious, not caused by anything you did wrong, and affects roughly 0.36% of the global population, or about 28.5 million people. The condition has no single cause. Instead, a combination of genetic susceptibility, immune system malfunction, oxidative stress, and environmental triggers converge to produce the characteristic white patches.
Your Immune System Attacks Pigment Cells
The white patches of vitiligo appear because melanocytes, the cells responsible for producing the pigment that colors your skin, are destroyed. The primary attackers are a specific type of immune cell that zeroes in on melanocytes, recognizes proteins on their surface, and kills them. These immune cells release molecules that punch holes in melanocyte membranes and trigger self-destruction pathways inside the cell.
The process doesn’t stop there. The attacking immune cells also release a signaling molecule called interferon-gamma, which does double damage: it makes melanocytes easier for the immune system to find, and it directly inhibits melanocyte growth and function. This creates a self-reinforcing cycle where inflammation attracts more immune cells, which cause more inflammation, which attracts still more immune cells. Natural killer cells, another branch of the immune system, add fuel by releasing chemical signals that draw even more attackers to the skin. This feedback loop is a key reason vitiligo patches can spread over time.
Genetics Load the Gun
Vitiligo has a strong genetic component, though no single gene causes it. Large-scale genetic studies have identified more than 30 genes linked to increased risk, most of them involved in immune regulation or melanocyte biology. Several of the strongest associations sit within a region of DNA responsible for helping immune cells distinguish “self” from “foreign.” When variants in this region alter how immune cells identify melanocytes, the risk of a misdirected attack rises.
Other risk genes affect how aggressively the immune system responds to perceived threats, how well melanocytes handle stress, and how pigment is produced in the first place. About one in five people with vitiligo has at least one close relative who also has the condition. But inheriting risk genes doesn’t guarantee you’ll develop vitiligo. Most people who carry susceptibility variants never get it, which is why environmental triggers matter so much.
Oxidative Stress Weakens Melanocytes
Before the immune system ever launches its attack, something has to make melanocytes vulnerable. One well-studied culprit is oxidative stress, specifically the buildup of hydrogen peroxide in the skin. Healthy skin neutralizes hydrogen peroxide with an enzyme called catalase. In people with active vitiligo, catalase levels in the skin are abnormally low, allowing hydrogen peroxide to accumulate to concentrations roughly a thousand times higher than normal.
At those levels, hydrogen peroxide damages proteins inside skin cells, disrupts calcium signaling (which cells need to function properly), and throws off the internal balance that keeps melanocytes alive. Research on vitiligo melanocytes has shown they are hypersensitive to this kind of oxidative injury because their internal stress-defense systems don’t activate properly. The damaged, stressed melanocytes then display altered surface markers that essentially flag them for immune destruction. In this way, oxidative stress acts as the opening move that sets the autoimmune cascade in motion.
Environmental and Physical Triggers
For someone with the right genetic background and underlying oxidative stress, specific environmental exposures can tip the balance. The best-documented chemical triggers are phenols, a class of industrial compounds found in certain hair dyes, rubber products, adhesives, and cleaning agents. Phenols are structurally similar to the building blocks of melanin, so they can infiltrate melanocytes, disrupt pigment production, and trigger cell death. Occupational exposure to phenol-containing chemicals is a recognized cause of “chemical vitiligo” that can later evolve into widespread autoimmune vitiligo.
Physical trauma to the skin is another well-known trigger, through a process called the Koebner phenomenon. Cuts, burns, sunburns, surgical wounds, friction from tight clothing, tattoos, and even piercings can provoke new white patches at the site of injury. The mechanism likely involves local inflammation and melanocyte damage at the wound site, which, in a person whose immune system is already primed against melanocytes, sparks a fresh round of destruction. Severe emotional stress is also frequently reported before onset or flares, likely because stress hormones amplify inflammation and oxidative damage in the skin.
Segmental vs. Non-Segmental Vitiligo
Not all vitiligo works the same way. The most common form, non-segmental vitiligo, produces symmetrical patches on both sides of the body and is driven by the systemic autoimmune process described above. Segmental vitiligo is different. It appears on only one side of the body, typically follows a band-like pattern along a nerve distribution, and usually stabilizes relatively quickly rather than spreading indefinitely.
Researchers believe segmental vitiligo originates from a genetic change that occurs during embryonic development, affecting only a localized group of melanocyte precursor cells. This is called somatic mosaicism, meaning a small population of cells carries a mutation the rest of the body does not. Studies of segmental vitiligo patches have found localized nerve abnormalities and nearly a threefold increase in blood flow in the affected skin, with heightened sympathetic nerve activity confined to that segment alone. Circulating stress hormones and nerve receptor density elsewhere in the body remain completely normal, confirming this is a local phenomenon rather than a whole-body one.
Autoimmune Connections
Because vitiligo is fundamentally an autoimmune condition, it tends to cluster with other autoimmune diseases. In one large study, 35% of vitiligo patients had at least one additional autoimmune disorder. Thyroid disease was by far the most common, affecting about 23% of patients. Rheumatoid arthritis, pernicious anemia (a condition where the body can’t absorb vitamin B12 properly), and alopecia areata each affected 2 to 3%. This overlap reflects the shared genetic wiring that predisposes someone to autoimmunity in general, not just to vitiligo specifically. If you develop vitiligo, thyroid function testing is a standard part of evaluation for this reason.
Who Develops Vitiligo
Vitiligo affects all skin types and ethnicities equally, though it is more visually apparent on darker skin. Globally, an estimated 37.1 million adults and 5.8 million children are living with the condition. It can start at any age, but most people notice their first patches before age 30. The condition affects men and women at similar rates.
Having a family member with vitiligo raises your risk, but most cases occur in people with no family history at all. The interplay between dozens of genetic variants, individual oxidative stress capacity, and unpredictable environmental exposures makes it impossible to predict who will develop vitiligo and who won’t. What is clear is that it results from biology, not behavior. You cannot catch vitiligo from someone, and you cannot cause it through diet, hygiene, or lifestyle choices.